Pharmafile Logo
Pharmafocus logo
Advanced Search
surinder

Hikma bring in new CSO

January 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hikma, biotech, drugs, pharma, pharmaceutical

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …

Appointment

Boehringer’s Gilotrif approved in US for lung cancer with non-resistant EGFRs

January 16, 2018
Manufacturing and Production, Sales and Marketing Boehringer Ingelheim, Cancer, FDA, Giltrif, NSCLC, lung cancer

Boehringer Ingelheim is celebrating the FDA’s decision to expand the indication of its lung cancer drug Gilotrif (afatinib) to include …

News
mundipharma

Mundipharma signs Chinese licensing and distribution agreement with Grünenthal

January 16, 2018
Manufacturing and Production China, Grunenthal, Mundipharma, Tramal, pharma

US-based firm Mundipharma is set to take over commercialisation and distribution duties for the analgesic Tramal (tramadol) in China on …

News
novartis_outside_1

Novartis debuts new data showing Cosentyx’s superiority over Janssen’s Stelara in psoriasis

January 16, 2018
Manufacturing and Production, Research and Development Cosentyx, Janssen, Novartis, Stelara, pharma

Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving …

News
teva_canada_1

FDA expands indication of Teva’s Trisenox for acute promyelocytic leukaemia

January 16, 2018
Manufacturing and Production, Sales and Marketing FDA, Teva, acute promyelocytic leukaemia, leukaemia, pharma

Teva has announced that its Trisenox (arsenic trioxide) injection has been awarded US approval from the FDA in combination with …

News
inhaler-2520472_960_720

Asthma carves $82 billion out of US economy every year

January 15, 2018
Manufacturing and Production, Medical Communications asthma, biotech, drugs, pharma, pharmaceutical

A study created by researchers at the Centers for Disease Control and Prevention has estimated that asthma is costing the …

News
heartbeat-3077960_960_720

Seizing opportunities in the next steps for real world evidence

January 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …

Feature
gavel_2

Teva settles with Israeli authorities over international bribery

January 15, 2018
Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Just over a year ago, Teva closed a case with US authorities by agreeing to pay a $519 million fine …

News
shire_image_4

Shire scores European approval for Adynovi in haemophilia A

January 15, 2018
Sales and Marketing Adynovi, Europe, European Commission, Shire, haemophilia, haemophilia a, pharma

Shire has revealed that the European Commission has approved Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in …

News
philippines-1195394_960_720

Sanofi agrees to reimburse Philippines’ Dengvaxia stockpiles

January 15, 2018
Sales and Marketing Philippines, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has agreed with the Department of Health (DoH) for the Philippines to reimburse $27.86 million worth of vaccines, though …

News
fda2outsideweb

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018
Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

News
flu

Universal flu vaccine receives Google’s financial backing

January 15, 2018
Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical

Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …

News
kid_ill

FDA steps in to prohibit codeine cough syrups for children

January 12, 2018
Medical Communications FDA, biotech, drugs, pharma, pharmaceutical

The FDA has announced that it will require all labels to state that cough syrups containing codeine or hydrocodone are …

News
roche_close

Roche’s Ocrevus gets the go ahead in Europe for two forms of MS

January 12, 2018
Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …

News
breast_cancer_awareness

BRCA gene mutation found not to impact survival

January 12, 2018
Medical Communications, Research and Development

The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was …

News
old_man_bar

Another Alzheimer’s drug bites the dust in P3

January 12, 2018
Medical Communications, Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and

News
barrett_novartis

Novartis prises Pfizer’s Oncology Head away

January 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

Appointment
teva_small

Teva execs feel the pinch, after pay halved

January 11, 2018
Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …

News

AZ’s Fasenra approved in Europe as an add-on for severe eosinophilic asthma

January 11, 2018
Research and Development AstraZeneca, European Commission, Fasenra, MedImmune, asthma, pharma

AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026